0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ceftazidime Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13H7943
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Ceftazidime Injection Market Insights and Forecast to 2028
BUY CHAPTERS

Global Ceftazidime Injection Market Research Report 2025

Code: QYRE-Auto-13H7943
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ceftazidime Injection Market

The global market for Ceftazidime Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Ceftazidime injection is a western medicine preparation, mainly used for respiratory tract infections and urinary tract infections caused by sensitive bacteria.Since the global outbreak of COVID-19, these drugs have also entered a stage of shortage .
North American market for Ceftazidime Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ceftazidime Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Ceftazidime Injection include Teligent, Pfizer, B Braun, Sagent, WG Critical Care, GSK, Allergan, CSPC Zhongnuo Pharmaceutical, Anhui Welman, Guangzhou Baiyunshan Tianxin Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ceftazidime Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ceftazidime Injection.
The Ceftazidime Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ceftazidime Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ceftazidime Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ceftazidime Injection Market Report

Report Metric Details
Report Name Ceftazidime Injection Market
Segment by Type
  • 1g/vial
  • 2g/vial
  • 6g/vial
Segment by Application
  • Hospital
  • Clinics
  • Recovery Center
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teligent, Pfizer, B Braun, Sagent, WG Critical Care, GSK, Allergan, CSPC Zhongnuo Pharmaceutical, Anhui Welman, Guangzhou Baiyunshan Tianxin Pharmaceutical, Hainan Hailing Chemipharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ceftazidime Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ceftazidime Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Ceftazidime Injection Market report?

Ans: The main players in the Ceftazidime Injection Market are Teligent, Pfizer, B Braun, Sagent, WG Critical Care, GSK, Allergan, CSPC Zhongnuo Pharmaceutical, Anhui Welman, Guangzhou Baiyunshan Tianxin Pharmaceutical, Hainan Hailing Chemipharma

What are the Application segmentation covered in the Ceftazidime Injection Market report?

Ans: The Applications covered in the Ceftazidime Injection Market report are Hospital, Clinics, Recovery Center

What are the Type segmentation covered in the Ceftazidime Injection Market report?

Ans: The Types covered in the Ceftazidime Injection Market report are 1g/vial, 2g/vial, 6g/vial

1 Ceftazidime Injection Market Overview
1.1 Product Definition
1.2 Ceftazidime Injection by Type
1.2.1 Global Ceftazidime Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 1g/vial
1.2.3 2g/vial
1.2.4 6g/vial
1.3 Ceftazidime Injection by Application
1.3.1 Global Ceftazidime Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Global Ceftazidime Injection Market Size Estimates and Forecasts
1.4.1 Global Ceftazidime Injection Revenue 2020-2031
1.4.2 Global Ceftazidime Injection Sales 2020-2031
1.4.3 Global Ceftazidime Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ceftazidime Injection Market Competition by Manufacturers
2.1 Global Ceftazidime Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ceftazidime Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ceftazidime Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ceftazidime Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ceftazidime Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ceftazidime Injection, Product Type & Application
2.7 Global Key Manufacturers of Ceftazidime Injection, Date of Enter into This Industry
2.8 Global Ceftazidime Injection Market Competitive Situation and Trends
2.8.1 Global Ceftazidime Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ceftazidime Injection Players Market Share by Revenue
2.8.3 Global Ceftazidime Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ceftazidime Injection Market Scenario by Region
3.1 Global Ceftazidime Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ceftazidime Injection Sales by Region: 2020-2031
3.2.1 Global Ceftazidime Injection Sales by Region: 2020-2025
3.2.2 Global Ceftazidime Injection Sales by Region: 2026-2031
3.3 Global Ceftazidime Injection Revenue by Region: 2020-2031
3.3.1 Global Ceftazidime Injection Revenue by Region: 2020-2025
3.3.2 Global Ceftazidime Injection Revenue by Region: 2026-2031
3.4 North America Ceftazidime Injection Market Facts & Figures by Country
3.4.1 North America Ceftazidime Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ceftazidime Injection Sales by Country (2020-2031)
3.4.3 North America Ceftazidime Injection Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ceftazidime Injection Market Facts & Figures by Country
3.5.1 Europe Ceftazidime Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ceftazidime Injection Sales by Country (2020-2031)
3.5.3 Europe Ceftazidime Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ceftazidime Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Ceftazidime Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ceftazidime Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Ceftazidime Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ceftazidime Injection Market Facts & Figures by Country
3.7.1 Latin America Ceftazidime Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ceftazidime Injection Sales by Country (2020-2031)
3.7.3 Latin America Ceftazidime Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ceftazidime Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Ceftazidime Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ceftazidime Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ceftazidime Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ceftazidime Injection Sales by Type (2020-2031)
4.1.1 Global Ceftazidime Injection Sales by Type (2020-2025)
4.1.2 Global Ceftazidime Injection Sales by Type (2026-2031)
4.1.3 Global Ceftazidime Injection Sales Market Share by Type (2020-2031)
4.2 Global Ceftazidime Injection Revenue by Type (2020-2031)
4.2.1 Global Ceftazidime Injection Revenue by Type (2020-2025)
4.2.2 Global Ceftazidime Injection Revenue by Type (2026-2031)
4.2.3 Global Ceftazidime Injection Revenue Market Share by Type (2020-2031)
4.3 Global Ceftazidime Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ceftazidime Injection Sales by Application (2020-2031)
5.1.1 Global Ceftazidime Injection Sales by Application (2020-2025)
5.1.2 Global Ceftazidime Injection Sales by Application (2026-2031)
5.1.3 Global Ceftazidime Injection Sales Market Share by Application (2020-2031)
5.2 Global Ceftazidime Injection Revenue by Application (2020-2031)
5.2.1 Global Ceftazidime Injection Revenue by Application (2020-2025)
5.2.2 Global Ceftazidime Injection Revenue by Application (2026-2031)
5.2.3 Global Ceftazidime Injection Revenue Market Share by Application (2020-2031)
5.3 Global Ceftazidime Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teligent
6.1.1 Teligent Company Information
6.1.2 Teligent Description and Business Overview
6.1.3 Teligent Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teligent Ceftazidime Injection Product Portfolio
6.1.5 Teligent Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Ceftazidime Injection Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 B Braun
6.3.1 B Braun Company Information
6.3.2 B Braun Description and Business Overview
6.3.3 B Braun Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 B Braun Ceftazidime Injection Product Portfolio
6.3.5 B Braun Recent Developments/Updates
6.4 Sagent
6.4.1 Sagent Company Information
6.4.2 Sagent Description and Business Overview
6.4.3 Sagent Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sagent Ceftazidime Injection Product Portfolio
6.4.5 Sagent Recent Developments/Updates
6.5 WG Critical Care
6.5.1 WG Critical Care Company Information
6.5.2 WG Critical Care Description and Business Overview
6.5.3 WG Critical Care Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 WG Critical Care Ceftazidime Injection Product Portfolio
6.5.5 WG Critical Care Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSK Ceftazidime Injection Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Allergan
6.7.1 Allergan Company Information
6.7.2 Allergan Description and Business Overview
6.7.3 Allergan Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Allergan Ceftazidime Injection Product Portfolio
6.7.5 Allergan Recent Developments/Updates
6.8 CSPC Zhongnuo Pharmaceutical
6.8.1 CSPC Zhongnuo Pharmaceutical Company Information
6.8.2 CSPC Zhongnuo Pharmaceutical Description and Business Overview
6.8.3 CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Product Portfolio
6.8.5 CSPC Zhongnuo Pharmaceutical Recent Developments/Updates
6.9 Anhui Welman
6.9.1 Anhui Welman Company Information
6.9.2 Anhui Welman Description and Business Overview
6.9.3 Anhui Welman Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Anhui Welman Ceftazidime Injection Product Portfolio
6.9.5 Anhui Welman Recent Developments/Updates
6.10 Guangzhou Baiyunshan Tianxin Pharmaceutical
6.10.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
6.10.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
6.10.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Product Portfolio
6.10.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
6.11 Hainan Hailing Chemipharma
6.11.1 Hainan Hailing Chemipharma Company Information
6.11.2 Hainan Hailing Chemipharma Description and Business Overview
6.11.3 Hainan Hailing Chemipharma Ceftazidime Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hainan Hailing Chemipharma Ceftazidime Injection Product Portfolio
6.11.5 Hainan Hailing Chemipharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ceftazidime Injection Industry Chain Analysis
7.2 Ceftazidime Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ceftazidime Injection Production Mode & Process Analysis
7.4 Ceftazidime Injection Sales and Marketing
7.4.1 Ceftazidime Injection Sales Channels
7.4.2 Ceftazidime Injection Distributors
7.5 Ceftazidime Injection Customer Analysis
8 Ceftazidime Injection Market Dynamics
8.1 Ceftazidime Injection Industry Trends
8.2 Ceftazidime Injection Market Drivers
8.3 Ceftazidime Injection Market Challenges
8.4 Ceftazidime Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Ceftazidime Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ceftazidime Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ceftazidime Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ceftazidime Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ceftazidime Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ceftazidime Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ceftazidime Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ceftazidime Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ceftazidime Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ceftazidime Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ceftazidime Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Ceftazidime Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ceftazidime Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ceftazidime Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ceftazidime Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ceftazidime Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ceftazidime Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Ceftazidime Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ceftazidime Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Ceftazidime Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ceftazidime Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Ceftazidime Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ceftazidime Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Ceftazidime Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ceftazidime Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ceftazidime Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ceftazidime Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ceftazidime Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ceftazidime Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ceftazidime Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ceftazidime Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ceftazidime Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ceftazidime Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ceftazidime Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ceftazidime Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ceftazidime Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ceftazidime Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ceftazidime Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ceftazidime Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ceftazidime Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ceftazidime Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ceftazidime Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ceftazidime Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ceftazidime Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ceftazidime Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ceftazidime Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ceftazidime Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ceftazidime Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ceftazidime Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Ceftazidime Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Ceftazidime Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Ceftazidime Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Ceftazidime Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ceftazidime Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ceftazidime Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Ceftazidime Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Ceftazidime Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ceftazidime Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ceftazidime Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Ceftazidime Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Ceftazidime Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Ceftazidime Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Ceftazidime Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ceftazidime Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ceftazidime Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Ceftazidime Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Ceftazidime Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ceftazidime Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Teligent Company Information
 Table 71. Teligent Description and Business Overview
 Table 72. Teligent Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Teligent Ceftazidime Injection Product
 Table 74. Teligent Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Ceftazidime Injection Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. B Braun Company Information
 Table 81. B Braun Description and Business Overview
 Table 82. B Braun Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. B Braun Ceftazidime Injection Product
 Table 84. B Braun Recent Developments/Updates
 Table 85. Sagent Company Information
 Table 86. Sagent Description and Business Overview
 Table 87. Sagent Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sagent Ceftazidime Injection Product
 Table 89. Sagent Recent Developments/Updates
 Table 90. WG Critical Care Company Information
 Table 91. WG Critical Care Description and Business Overview
 Table 92. WG Critical Care Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. WG Critical Care Ceftazidime Injection Product
 Table 94. WG Critical Care Recent Developments/Updates
 Table 95. GSK Company Information
 Table 96. GSK Description and Business Overview
 Table 97. GSK Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GSK Ceftazidime Injection Product
 Table 99. GSK Recent Developments/Updates
 Table 100. Allergan Company Information
 Table 101. Allergan Description and Business Overview
 Table 102. Allergan Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Allergan Ceftazidime Injection Product
 Table 104. Allergan Recent Developments/Updates
 Table 105. CSPC Zhongnuo Pharmaceutical Company Information
 Table 106. CSPC Zhongnuo Pharmaceutical Description and Business Overview
 Table 107. CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. CSPC Zhongnuo Pharmaceutical Ceftazidime Injection Product
 Table 109. CSPC Zhongnuo Pharmaceutical Recent Developments/Updates
 Table 110. Anhui Welman Company Information
 Table 111. Anhui Welman Description and Business Overview
 Table 112. Anhui Welman Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Anhui Welman Ceftazidime Injection Product
 Table 114. Anhui Welman Recent Developments/Updates
 Table 115. Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
 Table 116. Guangzhou Baiyunshan Tianxin Pharmaceutical Description and Business Overview
 Table 117. Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Guangzhou Baiyunshan Tianxin Pharmaceutical Ceftazidime Injection Product
 Table 119. Guangzhou Baiyunshan Tianxin Pharmaceutical Recent Developments/Updates
 Table 120. Hainan Hailing Chemipharma Company Information
 Table 121. Hainan Hailing Chemipharma Description and Business Overview
 Table 122. Hainan Hailing Chemipharma Ceftazidime Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hainan Hailing Chemipharma Ceftazidime Injection Product
 Table 124. Hainan Hailing Chemipharma Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Ceftazidime Injection Distributors List
 Table 128. Ceftazidime Injection Customers List
 Table 129. Ceftazidime Injection Market Trends
 Table 130. Ceftazidime Injection Market Drivers
 Table 131. Ceftazidime Injection Market Challenges
 Table 132. Ceftazidime Injection Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ceftazidime Injection
 Figure 2. Global Ceftazidime Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ceftazidime Injection Market Share by Type: 2024 & 2031
 Figure 4. 1g/vial Product Picture
 Figure 5. 2g/vial Product Picture
 Figure 6. 6g/vial Product Picture
 Figure 7. Global Ceftazidime Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Ceftazidime Injection Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinics
 Figure 11. Recovery Center
 Figure 12. Global Ceftazidime Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Ceftazidime Injection Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Ceftazidime Injection Sales (2020-2031) & (K Units)
 Figure 15. Global Ceftazidime Injection Average Price (US$/Unit) & (2020-2031)
 Figure 16. Ceftazidime Injection Report Years Considered
 Figure 17. Ceftazidime Injection Sales Share by Manufacturers in 2024
 Figure 18. Global Ceftazidime Injection Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Ceftazidime Injection Players: Market Share by Revenue in Ceftazidime Injection in 2024
 Figure 20. Ceftazidime Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Ceftazidime Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Ceftazidime Injection Sales Market Share by Country (2020-2031)
 Figure 23. North America Ceftazidime Injection Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Ceftazidime Injection Sales Market Share by Country (2020-2031)
 Figure 27. Europe Ceftazidime Injection Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Ceftazidime Injection Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Ceftazidime Injection Revenue Market Share by Region (2020-2031)
 Figure 35. China Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Ceftazidime Injection Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Ceftazidime Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Ceftazidime Injection Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Ceftazidime Injection Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Ceftazidime Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Ceftazidime Injection by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Ceftazidime Injection by Type (2020-2031)
 Figure 57. Global Ceftazidime Injection Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Ceftazidime Injection by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Ceftazidime Injection by Application (2020-2031)
 Figure 60. Global Ceftazidime Injection Price (US$/Unit) by Application (2020-2031)
 Figure 61. Ceftazidime Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart